baber/WOPTO huggingface dataset:
Patent AU-2016237412-A1 (AU)
Title: Drug portion packaging device
Inventor: AMANO HIROKAZU
IPC: A61J3/00
Filed: 2016-03-17
Abstract: [Problem] The purpose of the present invention is to provide a drug portion packaging device whereby high-quality printing can be applied to a portion packaging paper without a support stage or the like for the portion packaging paper being provided, while the drug portion packaging device is provided with a printing unit for jetting ink and printing. [Solution] A drug portion packaging device 10 has a drug feeding unit 20, a packaging unit 30, a portion packaging paper conveyance unit 40, and a printing unit 60. The printing unit 60 has an ink ejection unit 62 configured so as to be capable of ejecting ink downward. A conveyance path T of the portion packaging paper conveyance unit 40 has an intersecting-direction conveyance unit T1 for conveying portion packaging paper S in a direction intersecting with the ejection direction of the ink, and a first conveyance direction switching unit 46 and second conveyance direction switching unit 48 for changing the conveyance direction of the portion packaging paper S on an upstream side and a downstream side, with respect to the intersecting-direction conveyance unit T1, in the conveyance direction of the portion packaging paper S. The ink ejection unit 62 is arranged in a position separated a predetermined distance upward from the intersecting-direction conveyance unit T1.
Patent AU-2016239772-A1 (AU)
Title: Stable formulation for parenteral administration of Tapentadol
Inventor: SCHILLER MARC
IPC: A61K9/00
Filed: 2016-03-23
Abstract: The invention relates to an aqueous pharmaceutical composition for parenteral administration comprising Tapentadol or a physiologically acceptable salt thereof, wherein the concentration of Tapentadol is within the range of from 0.10 to 8.00mg/mL, based on the weight of Tapentadol free base and based on the total volume of the composition; and wherein the pH value of the composition is buffered and within the range of from 4.0 to 6.0. The invention also relates to a container comprising the pharmaceutical composition and a process for the preparation thereof. The invention also relates to a kit comprising the contained according to the invention in a packaging. The pharmaceutical composition according to the invention is particularly useful for treating pain, especially acute pain, preferably in pediatric patients.
Patent AU-2016256767-A1 (AU)
Title: System and method for tracking purchases
Inventor: HARRIS DAVID N
IPC: G06Q30/00
Filed: 2016-11-10
Abstract: A novel method for obtaining transaction information includes receiving a first transaction record including data indicative of one or more products purchased by a first purchaser from a first merchant, storing the data included in the first record, receiving a second transaction record including electronic data indicative of one or more products purchased by the purchaser from a second merchant, storing the data included in the second record, and providing the first purchaser access to the first transaction record and the said second transaction record. WO 2011/011067 PCT/US2010/002053 m PE 8-i!L to) o 0 3 : E '0 Co a cL
Patent AU-2016262624-A1 (AU)
Title: SRM/MRM assay for the mesothelin (MSLN) protein
Inventor: KRIZMAN DAVID B
IPC: G01N33/574
Filed: 2016-05-16
Abstract: The current disclosure provides methods for quantifying the MSLN protein directly in biological samples, including samples that have been fixed in formalin by Selected Reaction Monitoring/Multiple Reaction Monitoring (SRM/MRM) mass spectrometry. Samples that can be assayed include tissues and cells treated with formaldehyde containing agents/fixatives including formalin-fixed tissue/cells, formalin-fixed/paraffin embedded (FFPE) tissue/cells, FFPE tissue blocks and cells from those blocks, and tissue culture cells that have been formalin fixed and or paraffin embedded. Methods to prepare a protein sample from such a biological sample are provided and MSLN protein is quantitated by SRM/MRM mass spectrometry by quantitating in the protein sample at least one or more of the peptides described.
Patent AU-2016264363-A1 (AU)
Title: Cancer vaccine comprising mRNA encoding a M-like-protein
Inventor: LAWMAN MICHAEL J P
IPC: A61K39/09
Filed: 2016-05-19
Abstract: Synthetic bacterial messenger RNA can be used to prepare autologous, allogenic or direct nucleic acid cancer vaccines. Cancer cells are transfected either
Patent AU-2016266058-A1 (AU)
Title: S1P receptor modulators for treating multiple sclerosis
Inventor: HIESTAND PETER C
IPC: A61P37/06
Filed: 2016-12-01
Abstract: C:\NRPortbl\DCC\REC\4881025_1.DOC-1/23/2013 The present invention relates uses of an S1 P receptor modulator such as 2-substituted 2amino- propane-1,3-diol or 2-amino-propanol derivatives, e.g. a compound comprising a group of formula (X) z R3zR 2zN CH2R 1 (X) for the treatment or prevention of neo-angiogenesis associated with a demyelinating disease, e.g. multiple sclerosis.
Patent AU-2016271985-A1 (AU)
Title: Subsurface heater configuration for in situ hydrocarbon production
Inventor: WESENBERG MARGRETE HÅNES
IPC: E21B43/24
Filed: 2016-06-03
Abstract: The invention concerns a configuration of elongate subsurface heaters (20) in a subsurface oil shale formation (10) for use in hydrocarbon production. The heaters (20) are grouped into a series of columns (40), the columns extending generally perpendicular to the sedimentary layers (50) of the subsurface oil shale formation (10). The heaters may also be grouped into a series of layers, each layer extending in one sedimentary layer of the oil shale formation.
Patent AU-2016282475-A1 (AU)
Title: Compact spraying module, system for spraying and controlling a plurality of such modules, and method for controlling modules of such a system
Inventor: PELLENC ROGER
IPC: B05B3/10
Filed: 2016-06-23
Abstract: The present invention relates to a compact spraying module for spraying a liquid in the form of droplets (18) for treating a target. Said module includes a spraying unit (3) including a nozzle containing at least one spraying member and a fan that is capable of generating a carrying air flow in the nozzle and of carrying the droplets originating from said member to the target. Said module includes its own liquid supply system (7, 11) that and includes an electric pump (11), an electronic control and monitoring unit, a holder that keeps said pump near the spraying unit, an individual communication interface (20), and a power supply interface (20'). The invention also relates to a system for spraying and controlling a plurality of such modules and to a method for controlling modules of such a system.
Patent AU-2016319214-A1 (AU)
Title: Combination comprising immunostimulatory oligonucleotides
Inventor: SCHROFF MATTHIAS
IPC: C12N15/117
Filed: 2016-09-09
Abstract: The invention relates to a combination and its use for the treatment of diseases. The instant disclosure provides a combination of a so-called T-cell regulator selected from the group comprising PD1, PD-L1, OX40, TIM-3, LAG3, CD137(4-1BB) and a non-codiung immunomodulating DNA.
Patent AU-2016325979-A1 (AU)
Title: Information registration and authentication method and device
Inventor: SUN YUANBO
IPC: H04L9/32
Filed: 2016-09-13
Abstract: Disclosed are an information registration and authentication method and device. The registration method comprises: sending a standard information registration request to an authentication server; receiving first authentication information fed back by the authentication server; generating a standard information acquisition request, sending the standard information acquisition request and the first authentication information to a security information application, and acquiring signed standard information and an identity identifier of the standard information which are returned by the security information application after the authentication of the first authentication information is passed, wherein the signed standard information is signed by the security information application using second authentication information; and sending the signed standard information, the identity identifier of the standard information and the first authentication information to the authentication server, so that the authentication server registers the standard information and the identity identifier of the standard information after the authentication of the first authentication information is passed and the authentication of the second authentication information is passed according to the signed standard information.
Patent AU-2016352491-A1 (AU)
Title: Peptide thiourea derivative, radioisotope labeled compound containing same, and pharmaceutical composition containing same as active ingredient for treating or diagnosing prostate cancer
Inventor: JEONG JAE MIN
IPC: C07K5/072
Filed: 2016-11-09
Abstract: The present invention relates to a peptide thiourea derivative, a pharmaceutically acceptable salt thereof, a radioisotope labeled compound containing the same, and a pharmaceutical composition containing the same as an active ingredient for treating and diagnosing prostate cancer. The peptide thiourea derivative according to the present invention, when administered into the body, has excellent stability in the human serum, favorably binds to PSMA which is competitively expressed in prostate cancer, exhibits an excellent PSMA inhibitory effect with a low concentration, and can obtain a clear image of a prostate cancer tumor site by being excreted into the kidney rather than the hepatobiliary route due to high water solubility thereof. Therefore, the peptide thiourea derivative according to the present invention can be favorably used as a pharmaceutical composition for treating or diagnosing prostate cancer.
Patent AU-2016363926-A1 (AU)
Title: Dosing apparatus and a container
Inventor: PATERSON ANDREW JOHN
IPC: G01F11/26
Filed: 2016-10-14
Abstract: A dosing apparatus suitable for dispensing a dose of liquid from a resilient squeezable container, comprises: a cap, suitable for attachment to said container, said cap comprising an expulsion channel for the expulsion of liquid; a dosage chamber attached to said cap, said dosage chamber comprising side walls extending from said cap, at least one inlet opening in said side walls proximal to said cap; a pressure chamber located underneath said dosage chamber; a valve provided at the end of the pressure chamber distal to said dosage chamber, said valve being moveable from an open position, allowing liquid to flow through one or more discharge openings, and a closed position where the valve closes the or each discharge opening, said valve incorporating at least one aperture; and a plunger provided in said dosage chamber, and moveable relative to said dosage chamber so as to advance upon squeezing of said container, up to a blocking position.
Patent AU-2017200465-A1 (AU)
Title: Securing member for exterior members and exterior structure
Inventor: SUZUKI KENJI
IPC: E04F13/21
Filed: 2017-01-23
Abstract: A securing member includes a fixing portion having a reference surface and fixing holes, a main bulging portion having a contact surface that comes into contact with first to fourth exterior members, a supporting portion, upper and lower engagement portions attached to the supporting portion, a lower bulging portion, and an erected portion that projects from the lower bulging portion and that is disposed on a center line of the fixing portion between the first and third exterior members. One of the fixing holes that is closest to the center line is displaced from the center line. The fixing holes are arranged asymmetrically about the center line. A first length by which the main bulging portion bulges is greater than a second length by which the lower bulging portion bulges. The length from the reference surface to the front end of the erected portion is greater than the first length. [6/24] -UP LEFT INTERIOR 10B EXTERIOR RIGHT 15H (1 5T) DOWN 1B 15H 15H (1 5T) 015B 18 39 15E L15H 1 35-'' 18R 31 R
Patent AU-2017202973-A1 (AU)
Title: A closure for a container
Inventor: MCDOWELL CRAIG
IPC: B65D47/06
Filed: 2017-05-04
Abstract: This invention relates to a closure for sealing an opening of a container. In particular, the present invention relates to a closure (10) for sealing a mouth of a container, such as a bottle. According to a first aspect of the present invention there is provided a closure for sealing an opening defined by a mouth of a container, the closure comprising a body (12) adapted to overlie the mouth; and a discontinuous skirt (14) extending from the body, wherein the skirt is deformable between an open position and a closed position. The present invention also provides methods for applying the closure to a container. Fig. 4a., Fig. 4b. Fig. 4c,
Patent AU-2017216573-A1 (AU)
Title: Biogenic turbine and dieselfuel
Inventor: RUSEK JOHN J
IPC: C10L1/02
Filed: 2017-08-18
Abstract: Title: BIOGENIC TURBINE AND DIESEL FUEL The present invention provides fully renewable turbine and diesel fuels created from biomass sources. In one embodiment, the fully renewable turbine fuel is comprised of mesitylene and at least one alkane. Preferably, the turbine fuel comprises from about 50 to 99 wt% mesitylene and from about 1 to 50 wt% of at least one alkane. In another embodiment the diesel fuel comprises mesitylene, octadecane, and optionally octane or nonane. Preferably, the diesel fuel comprises from about 50 to 99 wt% mesitylene, and from about 1 to 50 wt% octadecane. These biomass derived fuels may be formulated to have a wide range of cetane values and differing freezing and boiling points. A preferred biogenic turbine fuel comprises one or more synthetic paraffinic kerosenes (SPK) and/or hydroprocessed renewable jet (HRJ) fuel; and between about 8 to 25 vol% of mesitylene. Another preferred biogenic turbine fuel is a blend of about 50% petroleum-based fuel; and about 50% of one or more of synthetic paraffinic kerosenes (SPK) and/or hydroprocessed renewable jet fuel (HRJ), and mesitylene.
Patent AU-2017254711-A1 (AU)
Title: Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use
Inventor: GRAY NATHANAEL
IPC: C07D401/14
Filed: 2017-04-21
Abstract: The present application provides bifunctional compounds of Formula (la) or (lb): or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which act as protein degradation inducing moieties for cyclin-dependent kinase 8 (CDK8). The present application also relates to methods for the targeted degradation of CDK8 through the use of the bifunctional compounds that link a ubiquitin ligase-bindmg moiety to a ligand that is capable of binding to CDK8 which can be utilized in the treatment of disorders modulated by CDK8.
Patent AU-2017256648-A1 (AU)
Title: Apparatus, system and method for alarm triggered electrical supply disconnection
Inventor: CHENG HONG
IPC: G01R31/00
Filed: 2017-04-27
Abstract: A system is described herein, including an activation circuit configured to generate a signal indicative of an alarm condition. A residual current device trigger circuit is coupled to the activation circuit and a residual current device. The residual current device trigger circuit is configured to provide a simulated earth leakage current condition to trigger the residual current device on receiving the signal indicative of the alarm condition.
Patent AU-2017277985-A1 (AU)
Title: Safening aminopyralid compositions in Brassica species with clopyralid and methods of use therof
Inventor: HARRIS BERNARD M
IPC: A01P13/00
Filed: 2017-06-02
Abstract: Provided herein are safened herbicidal compositions for use in Brassica species susceptible to injury by aminopyralid comprising (a) a herbicidally effective amount of aminopyralid or an agriculturally acceptable salt or ester of thereof, and (b) clopyralid or an agriculturally acceptable salt, ester, or combination thereof.
Patent AU-2017288933-A1 (AU)
Title: Systems and methods for dynamic occlusion handling
Inventor: YE MAO
IPC: G06T19/00
Filed: 2017-06-26
Abstract: A computing system includes a processing system with at least one processing unit. The processing system is configured to receive a depth map with a first boundary of an object. The processing system is configured to receive a color image that corresponds to the depth map. The color image includes a second boundary of the object. The processing system is configured to extract depth edge points of the first boundary from the depth map. The processing system is configured to identify target depth edge points on the depth map. The target depth edge points correspond to color edge points of the second boundary of the object in the color image. In addition, the processing system is configured to snap the depth edge points to the target depth edge points such that the depth map is enhanced with an object boundary for the object.
Patent AU-2017291812-A1 (AU)
Title: Bicyclic urea kinase inhibitors and uses thereof
Inventor: GRAY NATHANAEL S
IPC: A61P37/00
Filed: 2017-07-05
Abstract: The present disclosure provides compounds of Formula (I), (II), and (III). The provided compounds are able to bind protein kinases (
Patent AU-2017295048-A1 (AU)
Title: Method of producing concentrated or dried acid-gellable whey protein aggregates, and related compositions and food products
Inventor: ANDERSEN METTE MØLLER
IPC: A23C21/00
Filed: 2017-07-14
Abstract: The present invention relates to a novel method for preparing acid-gellable whey protein aggregates in the form of concentrated suspensions or powders. Moreover, the present invention relates to a novel composition containing the acid-gellable whey protein aggregates, to a food product ingredient comprising the novel type of acid-gellable whey protein composition, and to a food product comprising the novel type of acid-gellable whey protein composition.
Patent AU-2017302660-A1 (AU)
Title: Methods of treating prostate cancer
Inventor: GOTTARDIS MARCO
IPC: A61P35/00
Filed: 2017-07-28
Abstract: Disclosed are methods of treating prostate cancer by administering niraparib to a subject in need thereof.
Patent AU-2017322608-A1 (AU)
Title: A system for processing in real time healthcare data associated with submission and fulfillment of prescription drugs
Inventor: HILL KENNETH A
IPC: G06F16/00
Filed: 2017-09-11
Abstract: A system and methods for automatically processing healthcare data associated with submission and fulfillment of pharmaceutical prescriptions by providers in real time, including claim processing, are enabled by a clinical services platform configured with a review processor and operable with a clinical analytical message (CAM) data file. The system includes the use of first and second databases respectively containing pharmaceutical data and standardized healthcare data. This data is extracted during processing by the system and translated into a common format for storage in a third electronic patient outcome record (EPOR) that is accessible, with full security and patient safety, to authorized providers and patients.
Patent AU-2017323639-A1 (AU)
Title: Walking stick with integrated water filtration
Inventor: STRINGHAM KYLE COBB
IPC: B01D29/33
Filed: 2017-09-08
Abstract: An embodiment includes a walking stick. The walking stick includes a rod assembly, a water purification assembly, and a manual pump. The rod assembly extends from a first end to a second end that is opposite the first end along a longitudinal direction of the rod assembly. The rod assembly includes at least one rod portion. The water purification assembly is integrated with the rod assembly. The manual pump is configured to impose a pressure gradient in the water purification assembly. The manual pump includes a plunger that is physically coupled to a handle portion. Motion of the plunger relative to the water purification assembly draws water into an inlet tube that is positioned in the rod portion and through the water purification assembly. The motion of the plunger results from translation of the handle portion in substantially the longitudinal direction of the rod assembly.
Patent AU-2017329645-A1 (AU)
Title: Novel antibodies against factor XI and uses thereof
Inventor: WILMEN ANDREAS
IPC: A61K39/00
Filed: 2017-09-18
Abstract: The present invention in general relates to novel binding molecules, in particular antibodies and compositions and kits comprising the same. Said binding molecules are capable of binding to human Factor XI and hence envisaged to be particularly useful in inhibiting thrombosis without compromising hemostasis. The binding molecules, compositions and kits provided herein are therefore inter alia intended for treatment of thrombosis-related diseases and conditions. Moreover, polynucleotides encoding the binding molecules of the invention, vectors comprising said polynucleotides and host cells for producing the polynucleotides are provided herein.
Patent AU-2017342682-A1 (AU)
Title: A liquid system tool having an integrated residual current device
Inventor: ROSÉN MAGNUS
IPC: H02H7/08
Filed: 2017-10-13
Abstract: Disclosed herein is a liquid system tool having an integrated residual current device, RCD. The liquid system tool comprises a current circuit having a power input for receiving an alternating electrical current, AC, a rectifier for rectifying the AC into a direct current, DC, a voltage booster for increasing a DC voltage and a motor unit connected to an output of the voltage booster for driving the liquid system tool. The RCD comprises a sensor element connected to an output of the rectifier and an input of the voltage booster and being configured to collect an analog current signal and an analog to digital, A/D, converter configured to convert the analog current signal into a digital current signal. The integrated RCD further comprises a logic unit connected to the A/D converter, wherein the logic unit is configured to evaluate the digital current signal and compare it to a current requirement, and wherein if the logic unit determines that the digital current signal does not fulfill the current requirement, it is further configured to break the current circuit so that no current can flow in the liquid system tool. Also disclosed is a method for detecting residual current in a liquid system tool, and a computer program product.
Patent AU-2017348616-A1 (AU)
Title: Storage unit for a load, and storage system
Inventor: MADER TOBIAS
IPC: H02J3/32
Filed: 2017-10-27
Abstract: The invention relates to a storage unit (10) for a load, having a stored energy source (12), in which electrical energy can be stored. The storage unit (10) has a current interface (16), via which the storage unit (10) can be connected to an electrical grid (20). In addition, the storage unit (10) comprises a circuit assembly (14), which is arranged between the stored energy source (12) and the current interface (16) in the direction of current flow, and a server unit, which is designed to establish a decentralized computing network (52) with further server units, by means of which decentralized computing network transactions are managed, controlled and/or monitored in a decentralized manner. The invention further relates to a storage system (54).
Patent AU-2017363139-A1 (AU)
Title: Nucleic acid-based data storage
Inventor: ROQUET NATHANIEL
IPC: G16B45/00
Filed: 2017-11-16
Abstract: Methods and systems for encoding digital information in nucleic acid (e.g., deoxyribonucleic acid) molecules without base-by-base synthesis, by encoding bit-value information in the presence or absence of unique nucleic acid sequences within a pool, comprising specifying each bit location in a bit-stream with a unique nucleic sequence and specifying the bit value at that location by the presence or absence of the corresponding unique nucleic acid sequence in the pool But, more generally, specifying unique bytes in a bytestream by unique subsets of nucleic acid sequences. Also disclosed are methods for generating unique nucleic acid sequences without base-by-base synthesis using combinatorial genomic strategies (e.g., assembly of multiple nucleic acid sequences or enzymatic-based editing of nucleic acid sequences).